Related Experiment Video
Updated: Jul 26, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Thromboembolic complications after electrical cardioversion in patients with atrial flutter
A Elhendy1, F Gentile, B K Khandheria
1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Insights
Thromboembolic complications after atrial flutter cardioversion are rare (0.6%). Adequate anticoagulation appears to prevent embolic events in patients undergoing cardioversion for atrial flutter.
Area of Science:
- Cardiology
- Vascular Medicine
Background:
- Atrial flutter is a common arrhythmia requiring cardioversion.
- Thromboembolic complications are a significant concern post-cardioversion.
Purpose of the Study:
- To determine the incidence of thromboembolic complications following electrical cardioversion in patients diagnosed with atrial flutter.
- To assess the impact of anticoagulation on these complications.
Main Methods:
- Retrospective review of 615 elective electrical cardioversions in 493 patients with atrial flutter.
- Evaluation of embolic complications within 30 days post-cardioversion.
- Data collection via follow-up visits and physician contact.
Main Results:
- Successful cardioversion in 93% of procedures.
- A low incidence of thromboembolic events (0.6%) observed in 550 successful cardioversions with follow-up.
- No embolic events occurred in patients with adequate anticoagulation; 2 of 3 events occurred in non-anticoagulated patients.
Conclusions:
- Post-cardioversion thromboembolic complication rates in atrial flutter patients are low (0.6%).
- Adequate anticoagulation is associated with the absence of embolic events.
- These findings support current anticoagulation guidelines for atrial flutter cardioversion.
Purpose:
To determine the incidence of thromboembolic complications after cardioversion in patients with atrial flutter.
Subjects And Methods:
We reviewed 615 electrical cardioversions performed electively in 493 patients with atrial flutter. Embolic complications were evaluated during the 30 days after cardioversion. Follow-up data were obtained by follow-up visits and by contacting the treating physician.
Results:
Anticoagulants had been administered in 415 cardioversions (67%). Cardioversion was successful in 570 procedures (93%). Three embolic events (in 3 patients) occurred in the 30 days after 550 successful cardioversions with completed follow-up (0.6% of successful procedures; 95% confidence interval, 0.1% to 1.6%). Two of the 3 patients had not been anticoagulated, whereas the third patient had subtherapeutic oral anticoagulation. No embolic event occurred in procedures performed with adequate anticoagulation. The incidence of embolism in patients regardless of subtherapeutic anticoagulation was 1% (3 of 303 successful cardioversions).
Conclusions:
We observed a low (0.6%) incidence of postcardioversion thromboembolic complications in patients with atrial flutter. Embolic events did not occur in patients with adequate anticoagulation.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Venous Thrombosis III: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

